Home/Filings/4/0001363585-12-000003
4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001363585-12-000003

CIK 0001059784operating

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:25 PM ET

Size

5.6 KB

Accession

0001363585-12-000003

Insider Transaction Report

Form 4
Period: 2012-06-19
FLETCHER MARK
EVP & General Counsel
Transactions
  • Award

    Common Stock Purchase Option (right to buy)

    2012-06-19+1,457,1951,457,195 total
    Exercise: $0.00From: 2012-06-19Exp: 2017-06-19Common Stock (1,457,195 underlying)
Footnotes (1)
  • [F1]On June 6, 2012, the Board of Directors of the issuer granted the reporting person options to purchase 1,457,195 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 19, 2012. The grant was made pursuant to the terms of the issuer's 2006 stock plan.

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001059784

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:25 PM ET
Size
5.6 KB